Opportunity Research
Inscor Inc. is Poised to Help Relieve Municipal Distress

With few other low-cost solutions to the problem available and only ever-rising costs looming, Inscor (OTCPK – IOGA) has an opportunity to effect real change in government financial management and generate significant revenue for itself in the coming years.

Read more...
 
Health Benefits Down to a “T”

Until the arrival of Plandai Biotechnology, Inc. (OTCQB – PLPL), even many wellness pundits were unaware that substantial increases in bioavailability and effectiveness of some products, like green tea extracts, were possible and would change the face of the industry.

Read more...
 
Big Pharma Could Take Notice of Nuvilex Inc.

As broad development of its proprietary live-cell encapsulation platform delivery system progresses, it is possible that “Big Pharma” takes notice of Nuvilex Inc. (OTCQB – NVLX).

Read more...
 
Nuvilex Inc. Reminiscent of Major Biotech Success Stories

On May 14, 2013, Goldman Small Cap Research published an Article on Nuvilex, Inc. (OTCQB – NVLX).

Read more...
 
A Rare Bargain

Today we are issuing an updated report on LIG Assets (LIGA). LIG Assets may be one of the most successful opportunistic investors and financiers of its size and its strategy could result in $3-4M in net profit this year. Such a return is 4x the current market cap, making LIG’s share price a rare bargain.

Read more...
 
Nuvilex Inc. Affiliate Readies for Future Clinical Trials

Nuvilex Inc. Affiliate Readies for Future Clinical Trials

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 12

follow us on facebook

© 2013 Goldman Small Cap Research. All Rights Reserved

Solution Graphics